agtc.com · 462
Beacon Therapeutics is a pioneer in the field of ophthalmic gene therapy, dedicated to restoring and improving the vision of patients suffering from retinal diseases. The site focuses on the groundbreaking VISTA Trial, which aims to address conditions such as X-Linked Retinitis Pigmentosa (XLRP), Dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD) through innovative AAV gene therapy approaches. With a strong emphasis on science, clinical trials, and disease focus, Beacon Therapeutics offers a comprehensive overview of its pipeline, company, and the latest news and events in the field. Visitors can explore careers, learn more about the company's mission, and get in touch with the team. With a commitment to making remarkable advances in the field, Beacon Therapeutics is at the forefront of pioneering treatments that make a real difference in patients' lives.
agtc.com · years statistic
1996
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
1997
| 1 | 1 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
1998
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 1 |
| 12 | 1 |
1999
| 1 | 1 |
| 2 | 2 |
| 3 | 0 |
| 4 | 2 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2000
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 1 |
| 5 | 1 |
| 6 | 2 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2001
| 1 | 0 |
| 2 | 2 |
| 3 | 1 |
| 4 | 1 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 0 |
| 11 | 1 |
| 12 | 0 |
2002
| 1 | 1 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 2 |
| 10 | 0 |
| 11 | 3 |
| 12 | 0 |
2003
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 0 |
| 6 | 2 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 2 |
| 11 | 1 |
| 12 | 2 |
2004
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 2 |
| 5 | 2 |
| 6 | 1 |
| 7 | 3 |
| 8 | 1 |
| 9 | 3 |
| 10 | 0 |
| 11 | 0 |
| 12 | 2 |
2005
| 1 | 1 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 0 |
| 6 | 2 |
| 7 | 2 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2006
| 1 | 1 |
| 2 | 1 |
| 3 | 1 |
| 4 | 1 |
| 5 | 0 |
| 6 | 2 |
| 7 | 1 |
| 8 | 3 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2007
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 1 |
| 5 | 2 |
| 6 | 0 |
| 7 | 0 |
| 8 | 2 |
| 9 | 1 |
| 10 | 2 |
| 11 | 0 |
| 12 | 0 |
2008
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 2 |
| 6 | 1 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2009
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2011
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 2 |
| 8 | 3 |
| 9 | 1 |
| 10 | 1 |
| 11 | 3 |
| 12 | 1 |
2012
| 1 | 6 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 4 |
| 7 | 1 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2013
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 1 |
| 7 | 0 |
| 8 | 1 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2014
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 1 |
| 11 | 0 |
| 12 | 2 |
2015
| 1 | 0 |
| 2 | 3 |
| 3 | 1 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 2 |
| 8 | 3 |
| 9 | 3 |
| 10 | 1 |
| 11 | 1 |
| 12 | 1 |
2016
| 1 | 3 |
| 2 | 0 |
| 3 | 7 |
| 4 | 2 |
| 5 | 2 |
| 6 | 3 |
| 7 | 1 |
| 8 | 0 |
| 9 | 0 |
| 10 | 3 |
| 11 | 0 |
| 12 | 0 |
2017
| 1 | 1 |
| 2 | 0 |
| 3 | 1 |
| 4 | 2 |
| 5 | 1 |
| 6 | 3 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2018
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 2 |
| 5 | 1 |
| 6 | 1 |
| 7 | 1 |
| 8 | 3 |
| 9 | 1 |
| 10 | 1 |
| 11 | 3 |
| 12 | 8 |
2019
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 1 |
| 5 | 4 |
| 6 | 2 |
| 7 | 1 |
| 8 | 0 |
| 9 | 7 |
| 10 | 0 |
| 11 | 2 |
| 12 | 2 |
2020
| 1 | 6 |
| 2 | 1 |
| 3 | 0 |
| 4 | 2 |
| 5 | 12 |
| 6 | 1 |
| 7 | 1 |
| 8 | 0 |
| 9 | 2 |
| 10 | 5 |
| 11 | 5 |
| 12 | 1 |
2021
| 1 | 3 |
| 2 | 8 |
| 3 | 2 |
| 4 | 0 |
| 5 | 6 |
| 6 | 9 |
| 7 | 0 |
| 8 | 3 |
| 9 | 1 |
| 10 | 3 |
| 11 | 2 |
| 12 | 2 |
2022
| 1 | 0 |
| 2 | 6 |
| 3 | 5 |
| 4 | 2 |
| 5 | 3 |
| 6 | 6 |
| 7 | 11 |
| 8 | 8 |
| 9 | 10 |
| 10 | 12 |
| 11 | 8 |
| 12 | 9 |
2023
| 1 | 8 |
| 2 | 9 |
| 3 | 26 |
| 4 | 4 |
| 5 | 7 |
| 6 | 11 |
| 7 | 3 |
| 8 | 7 |
| 9 | 0 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2024
| 1 | 1 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
agtc.com · links
Healthcare
United States
English
rnioi.ru
475
National Medical Research Center of Oncology of the Ministry of Health of Russia
